Bipolar transurethral plasmakinetic prostatectomy for benign prostate hyperplasia(with the Report of 168 Cases)
Xuesong Chen, Xie Li-ren, Weibing Pan
Abstract
Xuesong Chen, Xie Li-ren, Weibing Pan
Abstract
Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostatectomy (TUPKP) in the treatment of benign prostate hyperplasia(BPH). Methods Summarize the clinical data of 168 patients with BPH treated with TUPKP. Results The resected tissues weighed 32 ~ 102 g,averaging 58 g. The operation lasted 32~105 min,averaging 65 min. No transurethral resection syndrome(TURS) occurred. Followed up for 3~6 months,differences in IPSS scores(25. 8±2. 7vs5. 0±2. 7) (P <0. 05) ,QOL scores(5.2±0. 5vs2. 0 ±0. 3) (P <0. 05) ,the MFR(8. 4±2. 1 ml/s vs2.5. 7±2. 1 ml/s) (P <0. 05 ) ,the AFR(5.5±0. 6 ml/s vs12. 2±1.6 ml/s) (P <0. 05) ,the RU( 151.2±40. 0 ml vs25.2±13.2 ml) (P<0. 05)respectively. Conclusions TUPKP for the treatment of BPH is effective and safe with few complications and is worth promoting. Key words: Benign prostatic hyperplasia; bipolar plasmakinetic resection; transurethral prostatectomy
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the curative effect of bipolar transurethral plasmakinetic prostatectomy (TUPKP) in the treatment of benign prostate hyperplasia(BPH). Methods Summarize the clinical data of 168 patients with BPH treated with TUPKP. Results The resected tissues weighed 32 ~ 102 g,averaging 58 g. The operation lasted 32~105 min,averaging 65 min. No transurethral resection syndrome(TURS) occurred. Followed up for 3~6 months,differences in IPSS scores(25. 8±2. 7vs5. 0±2. 7) (P <0. 05) ,QOL scores(5.2±0. 5vs2. 0 ±0. 3) (P <0. 05) ,the MFR(8. 4±2. 1 ml/s vs2.5. 7±2. 1 ml/s) (P <0. 05 ) ,the AFR(5.5±0. 6 ml/s vs12. 2±1.6 ml/s) (P <0. 05) ,the RU( 151.2±40. 0 ml vs25.2±13.2 ml) (P<0. 05)respectively. Conclusions TUPKP for the treatment of BPH is effective and safe with few complications and is worth promoting. Key words: Benign prostatic hyperplasia; bipolar plasmakinetic resection; transurethral prostatectomy
Key concepts: Urology, Hyperplasia, Medicine, Prostatectomy, Prostate, Resection, Benign prostatic hyperplasia (BPH), Transurethral resection of the prostate